It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We examined geographic and racial variation in cancer mortality within the state of Georgia, and investigated the correlation between the observed spatial differences and county-level characteristics. We analyzed county-level cancer mortality data collected by the Centers for Disease Control and Prevention on breast, colorectal, lung, and prostate cancer mortality among adults (aged ≥ 18 years) in 159 Georgia counties from years 1999 through 2019. Geospatial methods were applied, and we identified hot spot counties based on cancer mortality rates overall and stratified by non-Hispanic white (NH-white) and NH-black race/ethnicity. Among all adults, 5.0% (8 of 159), 8.2% (13 of 159), 5.0% (8 of 159), and 6.9% (11 of 159) of Georgia counties were estimated hot spots for breast cancer, colorectal, lung, and prostate cancer mortality, respectively. Cancer mortality hot spots were heavily concentrated in three major areas: (1) eastern Piedmont to Coastal Plain regions, (2) southwestern rural Georgia area, or (3) northern-most rural Georgia. Overall, hot spot counties generally had higher proportion of NH-black adults, older adult population, greater poverty, and more rurality. In Georgia, targeted cancer prevention strategies and allocation of health resources are needed in counties with elevated cancer mortality rates, focusing on interventions suitable for NH-black race/ethnicity, low-income, and rural residents.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Augusta University, Department of Medicine, Georgia Prevention Institute, Cancer Prevention, Control, & Population Health, Medical College of Georgia, Georgia Cancer Center, Augusta, USA (GRID:grid.410427.4) (ISNI:0000 0001 2284 9329); Augusta University, Institute of Preventive and Public Health, Medical College of Georgia, Augusta, USA (GRID:grid.410427.4) (ISNI:0000 0001 2284 9329)
2 Augusta University, Department of Medicine, Georgia Prevention Institute, Cancer Prevention, Control, & Population Health, Medical College of Georgia, Georgia Cancer Center, Augusta, USA (GRID:grid.410427.4) (ISNI:0000 0001 2284 9329)
3 Augusta University, Institute of Preventive and Public Health, Medical College of Georgia, Augusta, USA (GRID:grid.410427.4) (ISNI:0000 0001 2284 9329); Augusta University, Department of Population Health Sciences, Medical College of Georgia, Augusta, USA (GRID:grid.410427.4) (ISNI:0000 0001 2284 9329)
4 Augusta University, Institute of Preventive and Public Health, Medical College of Georgia, Augusta, USA (GRID:grid.410427.4) (ISNI:0000 0001 2284 9329)
5 Augusta University, Georgia Cancer Center, Augusta, USA (GRID:grid.410427.4) (ISNI:0000 0001 2284 9329)